Acs Pharmacology & Translational Science

Journal Title：Acs Pharmacology & Translational Science

acs Pharmacology & Translational Science Publishes High Quality, Innovative, And Impactful Research Across The Broad Spectrum Of Biological Sciences, Covering Basic And Molecular Sciences Through To Translational Preclinical Studies. Clinical Studies That Address Novel Mechanisms Of Action, And Methodological Papers That Provide Innovation, And Advance Translation, Will Also Be Considered. We Give Priority To Studies That Fully Integrate Basic Pharmacological And/or Biochemical Findings Into Physiological Processes That Have Translational Potential In A Broad Range Of Biomedical Disciplines. Therefore, Studies That Employ A Complementary Blend Of In Vitro And In Vivo Systems Are Of Particular Interest To The Journal. Nonetheless, All Innovative And Impactful Research That Has An Articulated Translational Relevance Will Be Considered.

《美国药理学与转化科学学会》发表涵盖广泛生物科学领域的高质量、创新且有影响力的研究，涵盖基础和分子科学直至转化临床前研究。涉及新作用机制的临床研究以及提供创新和先进转化的方法论文也将受到考虑。我们优先考虑将基础药理学和/或生化发现完全整合到生理过程的研究，这些研究在广泛的生物医学学科中具有转化潜力。因此，采用体外和体内系统互补混合的研究对期刊特别有吸引力。尽管如此，所有具有明确转化相关性的创新且有影响力的研究都将被考虑。

Acs Pharmacology & Translational Science创刊于2018年，由American Chemical Society出版商出版，收稿方向涵盖Medicine - Pharmacology (medical)全领域，平均审稿速度 ，影响因子指数4.9，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。